Here are five developments in orthobiologics to know since April 1:
1. Aurora-based University of Colorado Medicine opened the CU Medicine Regenerative Medicine, Hand and Spine Center in Englewood.
2. OssDesign's Catalyst nanosynthetic bone graft has been used in 1,000 patients, the medtech company said May 9.
3. Bioventus' CEO Ken Reali left his post on April 4. The company also sold its wound care segment to LifeNet Health.
4. eative Medical Technology Holdings' StemSpine procedure was found to be effective in treating chronic lower back pain, according to a pilot study.
5. Royal Biologics launched its Bio-Reign 3D bone graft substitute. Bio-Reign 3D is a natural hyper-crosslinked carbohydrate polymer bone graft substitute, according to a news release. It is radiolucent when implanted and becomes radioplaque as the bone heals.